SCHEMBL4522913

SCHEMBL4522913

O=C(c1ccc(F)cc1)c1cccnc1S

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.49
KMT2A Q03164 5/20 0.47
DHODH Q02127 3/20 0.44
NAPRT Q6XQN6 1/20 0.43
RAB9A P51151 5/20 0.43
NPC1 O15118 5/20 0.42
LMNA P02545 2/20 0.42
POLB P06746 1/20 0.42
RXFP1 Q9HBX9 1/20 0.41
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MEN1 O00255 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
EGFR P00533 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2163648 0.98 LTA4H (0.47) LTA4HKMT2ADHODHNAPRTRAB9A
SCHEMBL10519017 0.85 NAPRT (0.42) KMT2ADHODHNAPRTLMNAALDH1A1
SCHEMBL4511127 0.83 NR4A1 (0.53) KMT2ADHODHRAB9ANPC1LMNA
SCHEMBL5046047 0.83 NAPRT (0.59) LTA4HKMT2ADHODHNAPRTRAB9A
Hydrochloric Acid SCHEMBL2161994 0.82 NR4A1 (0.51) KMT2ADHODHRAB9ANPC1LMNA
SCHEMBL9236130 0.80 KMT2A (0.62) LTA4HKMT2ADHODHNAPRTRAB9A
SCHEMBL2679689 0.80 NAPRT (0.56) LTA4HKMT2ADHODHNAPRTRAB9A
SCHEMBL2212405 0.79 KDM4E (0.61) LTA4HKMT2ADHODHNAPRTRAB9A
SCHEMBL10480612 0.77 L3MBTL1 (0.49) LTA4HKMT2ADHODHRAB9ANPC1
SCHEMBL28134072 0.76 CYP1A2 (0.48) LTA4HKMT2ADHODHRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090326001-A1 THIENOPYRIDINE DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS RICHTER GEDEON NYRT. (HU) 2009-12-31 US disclosed
EP-1971609-A1 THIENOPYRIDINE DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Richter Gedeon NYRT (HU) 2008-09-24 EP disclosed
WO-2007072090-A1 THIENOPYRIDINE DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS RICHTER GEDEON NYRT. (HU) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326001-A1 THIENOPYRIDINE DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM5, GRM1, GRIK5 LTA4H 1285/4885KMT2A 2966/4885DHODH 2698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.